Trade Alert: Before I get to the new trade, reference last Friday's special alert on SPCX and PURR - we are monitoring both for breakouts. Details here. SPCX 240 Minute: Breaking out above $150. PURR 240 Minute SMMT — New PRO Trade Pending Summit Therapeutics has broken above an important intermediate-term declining trendline following encouraging Phase III results for ivonescimab. Longer-term support has held, while the 240-minute and 2-day charts are now providing technical confirmation. BUY PENDING: Jan. 15, 2027 $20 Calls — only upon continued confirmation of the breakout above the $17.50–$17.75 area. First technical objective is approximately $19.50, with a larger potential target in the $24–25 area if momentum continues. As always, our standard -50% option stop applies. SMMT 2-Day SMMT 240 Minute SMMT Jan $20 Call Big move into the mid-November - see Sep 2nd Press Release, i.e., "upcoming medical conference."
